In recent years there has been growing interest in the vitamins folic acid and vitamin B 12 because of the realization that the status of these vitamins in populations is less than adequate, and that such inadequacy may be linked to adverse public health outcomes. This concern has prompted the United States, Canada, and other countries to fortify grain products with folic acid, while additional countries are considering doing so in the near future. This presentation provides a new approach which relies on the combination of the concentrations in blood of vitamins and their respective functional indicators to establish cutoff points for assessing folate and vitamin B 12 status in populations. The premise is based on the fact that the relationship between plasma vitamin concentrations and their respective functional indicators is inverse and biphasic, with a steep slope at low concentrations of the vitamin and a more moderate slope at higher plasma vitamin concentrations. We propose that the intersection of these two slopes be used as a guideline for assessing the status of these vitamins and the adequacy of fortification programs. The cutoff would be 10 nmol/L for serum folate and 340 nmol/L for red blood cell folate, based on lowest plasma homocysteine. For serum vitamin B 12 , the cutoff would be 150 pmol/L based on lowest methylmalonic acid and 300 pmol/L based on lowest homocysteine.
Introduction
The vitamins folate and B 12 serve as coenzymes in one-carbon metabolism ( fig. 1) . In this metabolism, a carbon unit from serine or glycine reacts with tetrahydrofolate (THF) to form methylene-THF. This either is used for the synthesis of thymidylate, a DNA nucleotide, oxidized to formylated-THF for use in purine synthesis (DNA and RNA), or is irreversibly reduced to methyl-THF, which is used for the methylation of homocysteine to form methionine. The latter reaction is catalyzed by a methyltransferase, which has vitamin B 12 (methyl-B 12 ) as the prosthetic group. A considerable proportion of methionine is converted to S-adeno sylmethionine (SAM), a universal methyl donor for numerous vital methylation reactions. SAM is also a regulator of the one-carbon pathway; it is an allosteric inhibitor of methylenetetrahydrofolate reductase which catalyzes the synthesis of methyl-THF, and is an activator of cystathionine beta synthase, which catalyzes the major step in the conversion of excess homocysteine to cysteine. Impairments at various steps that affect remethylation of homocysteine to methionine or degradation of homocysteine to cysteine, including inadequate concentrations of folate or vitamin B 12 , will result in elevated homocysteine concentrations. Consequently, high circulating homocysteine concentrations are often an indication of inadequate status of these vitamins [1] . vitamin B 12 deficiency will lead to functional folate deficiency because the reduction of methylene-THF to methyl-THF is physiologically irreversible [2] . This functional deficiency occurs because much of the folate is "trapped" as the methyl derivatives reducing the availability of the nonmethylated folates, which serve as coenzymes for the synthesis of DNA and RNA and serine-glycine interconversion.
This methylfolate trap hypothesis emanated from clinical observations that both folate and vitamin B 12 deficiencies result in similar hematopoietic complications, including megaloblastic anemia and hypersegmentation of the bone marrow cells.
Vitamin B 12 deficiency is also associated with neurological complications, which include paresthesia, ataxia, loss of vibration or position sense, autonomic dysfunction, intellectual decline, and psychiatric disturbances [3] . In its most severe form, vitamin B 12 deficiency results in combined degeneration of the spinal cord. However, none of these neurological complications due to vitamin B 12 deficiency are expressed in folate deficiency. "Masking" of pernicious anemia refers to findings of early studies which showed that high doses of folic acid reversed the hematological complications of pernicious or megaloblastic anemia due to vitamin B 12 deficiency, but had no effect on the neurological complications. Some investigators even maintain that it precipitated the neurological complications.
For quite some time, these hematological/neurological complications were used for assessing the clinical impact of folate and vitamin B 12 deficiencies. However, because these clinical conditions are relatively rare, particularly in affluent societies, the prevalence of folate and vitamin B 12 deficiencies was considered to be low, and interest in these vitamins was limited. This has changed with the discovery that periconceptional intake of folic acid prevents births affected by neural tube defects (NTD) [4] , and the mounting evidence suggesting that mild elevations of homocysteine in plasma are associated with occlusive vascular disease and neurological dysfunctions [5] . Neither the mothers with NTD-affected births, nor those with slight elevations of plasma homocysteine, were folate-(or vitamin B 12 -) deficient according to clinical criteria. In fact, evidence now suggests that long-term exposure to inadequate status, or subclinical deficiencies of these vitamins, may be deleterious to a person's health. This conviction has increased the search for a means to better understand how to assess the status of these vitamins.
The relationship between folate status and NTD has resulted in the implementation of folic acid fortification of the food supply in a small number of countries, but the planning for fortification is under way in many others. One of the major safety considerations in the planning and implementation of folic acid fortification has been the potential masking of vitamin B 12 deficiency by high intakes of folic acid [6] . However, the planning of folic acid fortification is hampered by the lack of consensus on the best means of assessing vitamin status and on the definition of adequate concentrations of these vitamins. There are two approaches for assessing the nutritional status of these two vitamins: one that is based on direct measurements of plasma and/or red blood cell concentrations of these vitamins, and one that is based on functional indicators. Our task is to examine the utility of these two types of tests and to consider approaches to attain consensus on the definition of adequate status of these vitamins. 
Direct measurement of folate and vitamin B 12 status
One of the difficulties in establishing such a consensus lies in the fact that plasma concentrations of these vitamins, as well as the respective functional indicators, differ according to age and gender. Data from the third National Health and Nutrition Examination Survey (NHANES III) in the United States show that the distribution of serum folate concentrations is considerably higher at older ages in both males and females [7] . For example, serum folate concentrations in those over the age of 60 years are almost twice as high as those at the age of 12 to 19 years. The same pattern is seen with red blood cell folate [7] . Red blood cell folate increases with age for both men and women, and it is particularly high in those aged > 60 years. The relationship between serum and red blood cell folate also appears to differ somewhat across the various age groups, but the age-related differences are present only at the highest concentrations of serum folate. In the younger males and females, particularly those aged 12 to 19 years, the red blood cell concentrations appear to be lower at higher serum folate concentrations.
The pattern of serum vitamin B 12 concentrations among the different age groups is quite different from those of serum and red blood cell folate concentrations [7] . Here, the concentration of vitamin B 12 appears to decrease with age. All percentile values are highest in the youngest men and women, and the oldest men (age ≥ 60 years) have notably lower concentrations than the younger men, except at very high serum vitamin B 12 concentrations.
The complete shift in the age distributions of circulating folate and vitamin B 12 concentrations complicates the use of such direct measures of status to determine if a low value does indeed indicate a vitamin deficiency. Nor is it possible to establish, based on such data, an optimum vitamin concentration in plasma or red blood cells that will be applicable for all age groups.
Functional indicators of folate and vitamin B 12 status
One of the most important features of the metabolism of folate and vitamin B 12 is that it involves many enzymatic reactions with well-defined products and intermediates ( fig. 1) . Megaloblastic anemia is ascribed to thymidylate deficiency, due to unavailability of nonmethylated folate in folate and vitamin B 12 deficiencies to serve as a cofactor for the synthesis of this nucleotide. Formiminoglutamic acid (FIGLU) urinary excretion after a histidine load, and the deoxyuridine suppression test, are two tests for the assessment of the status of these vitamins that were used in the past [8] . One of the most promising methods of functional assessment of the status of these two vitamins is determining products of biological methylations. In recent studies we have shown that folate deficiency in young rats is associated with hepatic hypomethylation of isoaspartyl residues in proteins [9] . In a second study, we have shown that the combination of low folate status and the C677T mutation in the MTHFR gene is associated with DNA hypomethylation in humans [10] . One of the potential advantages of assessing methylation status is that there are numerous methylation reactions, and determining the status of a specific methylation product could provide more specific information on related clinical malfunctions.
Currently, however, the most important functional indicators are plasma total homocysteine concentrations for folate and vitamin B 12 , and methylmalonic acid concentrations for vitamin B 12 [11, 12] . Homocysteine stands at the intersection of two pathways: methylation, which requires both folate and vitamin B 12 , and transsulfuration, which uses a vitamin-B 6 coenzyme for forming cystathionine from serine and homocysteine ( fig. 1) . Because the cellular homocysteine concentration is tightly regulated, any excess of this amino acid is transported into the blood compartment. These features make plasma homocysteine concentrations a good indicator of folate and vitamin B 12 status. Vitamin B 12 in the form of adenosyl-B 12 is involved in a second reaction: the conversion of methylmalonyl-CoA to succinyl-CoA ( fig. 1) . In vitamin B 12 deficiency, MMA accumulates in the serum and is high in the urine. Figure 2 shows that plasma homocysteine concentration is higher in men than in women and increases considerably with age [13] . This is consistent with the fact that the plasma homocysteine level is also affected by other factors, including gender, age, renal function, and a number of lifestyle factors. Figure 3 shows the results of a recent study from our laboratory that examined serum concentrations of MMA in two groups from the NHANES III population, one aged 30 to 39 years (n = 1,026) and one aged ≥ 65 years (n = 1,145) [14] . The MMA serum concentration is significantly higher in the older than in the younger age group. Figure 4 shows the plot of the relationship between folate concentrations and homocysteine concentrations in serum from NHANES III, in both males and females after adjustment for serum vitamin B 12 and creatinine. Irrespective of age and gender, this relationship is biphasic: at low folate concentrations, homocysteine concentrations increase as folate concentration falls [13] . At higher folate concentrations, homocysteine remains unchanged. However, in spite of this similarity, the relationship curves differ in absolute serum homocysteine concentrations, being higher in men than in women, and higher with increasing age.
After adjustment for folate and creatinine, the rela- . 5) . This relationship, however, differs from that seen with folate by exhibiting shallower curves, particularly in the three lower age groups of the women. This is likely a consequence of the low prevalence of inadequate vitamin B 12 concentrations in the younger women. In the older men and women, however, this relationship between vitamin B 12 and homocysteine is more pronounced, which reflects the fact that in this group the high prevalence of low serum vitamin B 12 is an indicator of inadequate status of this vitamin. Figure 6 shows that after adjustment for plasma creatinine, which affects MMA concentrations, the relationship between serum vitamin B 12 and MMA concentrations is biphasic, particularly in the elderly group, where a considerable proportion has a low vitamin B 12 status.
Taken together, these data do not provide clear evidence whether these differences in blood folate or plasma homocysteine concentrations seen in the different age and gender groups represent differences in folate status. For example, it is not clear whether the high serum and red blood cell folate seen in the elderly represents an oversupply of this vitamin or if it reflects the propensity of the older people, as opposed to the younger group, to retain folate in both plasma and red blood cells. It is also not clear why age and gender have this profound effect on plasma homocysteine concentrations.
More importantly, however, the question is whether these data can help to establish an optimum or target value of serum folate and vitamin B 12 concentrations. Such a value would prove useful as a basis for the planning and subsequent evaluations of programs on fortification of foods with these vitamins. Because the relationship between serum vitamin concentrations and their respective functional indicators is biphasic and parallel, we constructed two-phase regression models to estimate the serum vitamin concentration at which the functional indicators achieved a minimum or optimum level. This procedure minimizes the sums of squares for two intersecting lines by considering successive ordered x-values as the location of a change point, that is, the point at which the lines intersect. As shown in figure 7, for serum folate the value at which an optimum homocysteine concentration is achieved is approximately 10 nmol/L (table 1). The cutoff value for red blood cell folate based on plasma homocysteine is 340 nmol/L (table 1). For vitamin B 12 , the two-phase regression curves for MMA gives the cutoff value of 150 pmol/L ( fig. 8a and table 1) . For homocysteine, the fig. 8b and table 1) . This difference in cutoff values for vitamin B 12 could reflect differences in affinities of the adenosyl vitamin B 12 coenzyme for its respective MMA-CoA mutase versus that of methyl vitamin B 12 for its respective homocysteine-methyltransferase. Other reasons for this difference cannot be ruled out at present. These include the facts that most vitamin B 12 in plasma is in the form of methyl-B 12 and that the vitamin B 12 -dependent methyltransferase is known to undergo continuous deactivation due to spontaneous oxidation of the Co +1 to Co +2 , which may require more vitamin B 12 .
Folic acid fortification and folate status
Folic acid fortification of grain products in the United States has dramatically affected folate status, assessed using either direct measures or functional indicators. For example, the mean folate concentration in the Framingham Study increased from around 10 nmol/L before fortification to twice that concentration after fortification [15] . The mean plasma folate after fortification falls well above the estimated value at which minimum homocysteine is achieved ( fig. 7) . Furthermore, prior to fortification, the first four quintile categories of plasma folate were associated with significantly higher homocysteine concentrations than the fifth (highest) quintile category ( fig. 9 ), whereas after fortification only the first quintile of plasma folate had significantly higher homocysteine than the fifth quintile.
Conclusions
Direct measures of folate and vitamin B 12 concentrations have become critical adjuncts to clinical assessment for determination of vitamin inadequacy, but now the former are being used in conjunction with functional indicators to assess adequate status of these vitamins. As countries begin to develop and monitor the implementation of folic acid fortification programs designed to reduce the risk of NTD-affected pregnancies, consensus on the appropriate vitamin status markers and concentrations that are associated with a low risk of vitamin deficiency will be of considerable aid.
We have illustrated one approach to the problem that combines information on both direct and functional indicators of vitamin status. However, this approach is by no means final, as was best illustrated in the case of vitamin B 12 where the two different functional indicators provided different minimum cut points. Though a cut-point of 150 pmol/L is consistent with many clinical data indicating that this is the upper value of the lower limit, we should consider the possibility that a cut-point of 300 pmol/L may apply to a specific segment of the population, e.g., the elderly, where vitamin B 12 -related impairment is more prevalent. Similarly, it is clear that a red blood cell value for folate of 340 nmol/L is not adequate for the prevention of NTD-affected births. It is therefore important that these numbers, representing a minimum of adequacy for metabolic functions, should be used as reference points to assess the need for, and subsequently the adequacy of, fortification programs for any given population. Furthermore, because of the large number of functions of folate and vitamin B 12 , newer, more specific measures, including the use of disease-based epidemiological data, may ultimately replace or augment the use of less specific functional measures such as homocysteine concentrations, and provide us with even more reliable indicators of vitamin adequacy in the future.
